Global Transcriptomics Technologies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Transcriptomics Technologies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID : 103160
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Transcriptomics Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Transcriptomics Technologies market size is estimated to be worth US$ 4205.2 million in 2021 and is forecast to a readjusted size of USD 7498.3 million by 2028 with a CAGR of 8.6% during review period. Clinical Diagnostics accounting for % of the Transcriptomics Technologies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Microarrays segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Transcriptomics Technologies include Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., and Illumina, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Transcriptomics Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Microarrays

Polymerase Chain Reaction (PCR)

Gene Regulation Technologies

Next Generation Sequencing (NGS)

Market segment by Application, can be divided into

Clinical Diagnostics

Drug Discovery and Research

Bioinformatics

Comparative Transcriptomics Studies

Market segment by players, this report covers

Affymetrix, Inc.

Thermo Fisher Scientific

Agilent Technologies

F-Hoffmann La Roche Ltd.

Illumina, Inc.

Life Technologies Corporation

Qiangen N.V.

LC Sciences

Sigma-Aldrich Corp

Danaher Corp

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Transcriptomics Technologies product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Transcriptomics Technologies, with revenue, gross margin and global market share of Transcriptomics Technologies from 2019 to 2022.

Chapter 3, the Transcriptomics Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transcriptomics Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Transcriptomics Technologies research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Transcriptomics Technologies

1.2 Classification of Transcriptomics Technologies by Type

1.2.1 Overview: Global Transcriptomics Technologies Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Transcriptomics Technologies Revenue Market Share by Type in 2021

1.2.3 Microarrays

1.2.4 Polymerase Chain Reaction (PCR)

1.2.5 Gene Regulation Technologies

1.2.6 Next Generation Sequencing (NGS)

1.3 Global Transcriptomics Technologies Market by Application

1.3.1 Overview: Global Transcriptomics Technologies Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinical Diagnostics

1.3.3 Drug Discovery and Research

1.3.4 Bioinformatics

1.3.5 Comparative Transcriptomics Studies

1.4 Global Transcriptomics Technologies Market Size & Forecast

1.5 Global Transcriptomics Technologies Market Size and Forecast by Region

1.5.1 Global Transcriptomics Technologies Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Transcriptomics Technologies Market Size by Region, (2017-2022)

1.5.3 North America Transcriptomics Technologies Market Size and Prospect (2017-2028)

1.5.4 Europe Transcriptomics Technologies Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Transcriptomics Technologies Market Size and Prospect (2017-2028)

1.5.6 South America Transcriptomics Technologies Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Transcriptomics Technologies Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Transcriptomics Technologies Market Drivers

1.6.2 Transcriptomics Technologies Market Restraints

1.6.3 Transcriptomics Technologies Trends Analysis

2 Company Profiles

2.1 Affymetrix, Inc.

2.1.1 Affymetrix, Inc. Details

2.1.2 Affymetrix, Inc. Major Business

2.1.3 Affymetrix, Inc. Transcriptomics Technologies Product and Solutions

2.1.4 Affymetrix, Inc. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Affymetrix, Inc. Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific Transcriptomics Technologies Product and Solutions

2.2.4 Thermo Fisher Scientific Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 Agilent Technologies

2.3.1 Agilent Technologies Details

2.3.2 Agilent Technologies Major Business

2.3.3 Agilent Technologies Transcriptomics Technologies Product and Solutions

2.3.4 Agilent Technologies Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Agilent Technologies Recent Developments and Future Plans

2.4 F-Hoffmann La Roche Ltd.

2.4.1 F-Hoffmann La Roche Ltd. Details

2.4.2 F-Hoffmann La Roche Ltd. Major Business

2.4.3 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Product and Solutions

2.4.4 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 F-Hoffmann La Roche Ltd. Recent Developments and Future Plans

2.5 Illumina, Inc.

2.5.1 Illumina, Inc. Details

2.5.2 Illumina, Inc. Major Business

2.5.3 Illumina, Inc. Transcriptomics Technologies Product and Solutions

2.5.4 Illumina, Inc. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Illumina, Inc. Recent Developments and Future Plans

2.6 Life Technologies Corporation

2.6.1 Life Technologies Corporation Details

2.6.2 Life Technologies Corporation Major Business

2.6.3 Life Technologies Corporation Transcriptomics Technologies Product and Solutions

2.6.4 Life Technologies Corporation Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Life Technologies Corporation Recent Developments and Future Plans

2.7 Qiangen N.V.

2.7.1 Qiangen N.V. Details

2.7.2 Qiangen N.V. Major Business

2.7.3 Qiangen N.V. Transcriptomics Technologies Product and Solutions

2.7.4 Qiangen N.V. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Qiangen N.V. Recent Developments and Future Plans

2.8 LC Sciences

2.8.1 LC Sciences Details

2.8.2 LC Sciences Major Business

2.8.3 LC Sciences Transcriptomics Technologies Product and Solutions

2.8.4 LC Sciences Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 LC Sciences Recent Developments and Future Plans

2.9 Sigma-Aldrich Corp

2.9.1 Sigma-Aldrich Corp Details

2.9.2 Sigma-Aldrich Corp Major Business

2.9.3 Sigma-Aldrich Corp Transcriptomics Technologies Product and Solutions

2.9.4 Sigma-Aldrich Corp Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sigma-Aldrich Corp Recent Developments and Future Plans

2.10 Danaher Corp

2.10.1 Danaher Corp Details

2.10.2 Danaher Corp Major Business

2.10.3 Danaher Corp Transcriptomics Technologies Product and Solutions

2.10.4 Danaher Corp Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Danaher Corp Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Transcriptomics Technologies Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Transcriptomics Technologies Players Market Share in 2021

3.2.2 Top 10 Transcriptomics Technologies Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Transcriptomics Technologies Players Head Office, Products and Services Provided

3.4 Transcriptomics Technologies Mergers & Acquisitions

3.5 Transcriptomics Technologies New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Transcriptomics Technologies Revenue and Market Share by Type (2017-2022)

4.2 Global Transcriptomics Technologies Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Transcriptomics Technologies Revenue Market Share by Application (2017-2022)

5.2 Global Transcriptomics Technologies Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Transcriptomics Technologies Revenue by Type (2017-2028)

6.2 North America Transcriptomics Technologies Revenue by Application (2017-2028)

6.3 North America Transcriptomics Technologies Market Size by Country

6.3.1 North America Transcriptomics Technologies Revenue by Country (2017-2028)

6.3.2 United States Transcriptomics Technologies Market Size and Forecast (2017-2028)

6.3.3 Canada Transcriptomics Technologies Market Size and Forecast (2017-2028)

6.3.4 Mexico Transcriptomics Technologies Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Transcriptomics Technologies Revenue by Type (2017-2028)

7.2 Europe Transcriptomics Technologies Revenue by Application (2017-2028)

7.3 Europe Transcriptomics Technologies Market Size by Country

7.3.1 Europe Transcriptomics Technologies Revenue by Country (2017-2028)

7.3.2 Germany Transcriptomics Technologies Market Size and Forecast (2017-2028)

7.3.3 France Transcriptomics Technologies Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Transcriptomics Technologies Market Size and Forecast (2017-2028)

7.3.5 Russia Transcriptomics Technologies Market Size and Forecast (2017-2028)

7.3.6 Italy Transcriptomics Technologies Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Transcriptomics Technologies Revenue by Type (2017-2028)

8.2 Asia-Pacific Transcriptomics Technologies Revenue by Application (2017-2028)

8.3 Asia-Pacific Transcriptomics Technologies Market Size by Region

8.3.1 Asia-Pacific Transcriptomics Technologies Revenue by Region (2017-2028)

8.3.2 China Transcriptomics Technologies Market Size and Forecast (2017-2028)

8.3.3 Japan Transcriptomics Technologies Market Size and Forecast (2017-2028)

8.3.4 South Korea Transcriptomics Technologies Market Size and Forecast (2017-2028)

8.3.5 India Transcriptomics Technologies Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Transcriptomics Technologies Market Size and Forecast (2017-2028)

8.3.7 Australia Transcriptomics Technologies Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Transcriptomics Technologies Revenue by Type (2017-2028)

9.2 South America Transcriptomics Technologies Revenue by Application (2017-2028)

9.3 South America Transcriptomics Technologies Market Size by Country

9.3.1 South America Transcriptomics Technologies Revenue by Country (2017-2028)

9.3.2 Brazil Transcriptomics Technologies Market Size and Forecast (2017-2028)

9.3.3 Argentina Transcriptomics Technologies Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Transcriptomics Technologies Revenue by Type (2017-2028)

10.2 Middle East & Africa Transcriptomics Technologies Revenue by Application (2017-2028)

10.3 Middle East & Africa Transcriptomics Technologies Market Size by Country

10.3.1 Middle East & Africa Transcriptomics Technologies Revenue by Country (2017-2028)

10.3.2 Turkey Transcriptomics Technologies Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Transcriptomics Technologies Market Size and Forecast (2017-2028)

10.3.4 UAE Transcriptomics Technologies Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Transcriptomics Technologies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Transcriptomics Technologies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Transcriptomics Technologies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Transcriptomics Technologies Revenue (USD Million) by Region (2017-2022)

Table 5. Global Transcriptomics Technologies Revenue Market Share by Region (2023-2028)

Table 6. Affymetrix, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Affymetrix, Inc. Major Business

Table 8. Affymetrix, Inc. Transcriptomics Technologies Product and Solutions

Table 9. Affymetrix, Inc. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific Transcriptomics Technologies Product and Solutions

Table 13. Thermo Fisher Scientific Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 15. Agilent Technologies Major Business

Table 16. Agilent Technologies Transcriptomics Technologies Product and Solutions

Table 17. Agilent Technologies Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. F-Hoffmann La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 19. F-Hoffmann La Roche Ltd. Major Business

Table 20. F-Hoffmann La Roche Ltd. Transcriptomics Technologies Product and Solutions

Table 21. F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Illumina, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Illumina, Inc. Major Business

Table 24. Illumina, Inc. Transcriptomics Technologies Product and Solutions

Table 25. Illumina, Inc. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Life Technologies Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Life Technologies Corporation Major Business

Table 28. Life Technologies Corporation Transcriptomics Technologies Product and Solutions

Table 29. Life Technologies Corporation Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Qiangen N.V. Corporate Information, Head Office, and Major Competitors

Table 31. Qiangen N.V. Major Business

Table 32. Qiangen N.V. Transcriptomics Technologies Product and Solutions

Table 33. Qiangen N.V. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. LC Sciences Corporate Information, Head Office, and Major Competitors

Table 35. LC Sciences Major Business

Table 36. LC Sciences Transcriptomics Technologies Product and Solutions

Table 37. LC Sciences Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sigma-Aldrich Corp Corporate Information, Head Office, and Major Competitors

Table 39. Sigma-Aldrich Corp Major Business

Table 40. Sigma-Aldrich Corp Transcriptomics Technologies Product and Solutions

Table 41. Sigma-Aldrich Corp Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Danaher Corp Corporate Information, Head Office, and Major Competitors

Table 43. Danaher Corp Major Business

Table 44. Danaher Corp Transcriptomics Technologies Product and Solutions

Table 45. Danaher Corp Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Transcriptomics Technologies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Transcriptomics Technologies Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Transcriptomics Technologies by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Transcriptomics Technologies Players Head Office, Products and Services Provided

Table 50. Transcriptomics Technologies Mergers & Acquisitions in the Past Five Years

Table 51. Transcriptomics Technologies New Entrants and Expansion Plans

Table 52. Global Transcriptomics Technologies Revenue (USD Million) by Type (2017-2022)

Table 53. Global Transcriptomics Technologies Revenue Share by Type (2017-2022)

Table 54. Global Transcriptomics Technologies Revenue Forecast by Type (2023-2028)

Table 55. Global Transcriptomics Technologies Revenue by Application (2017-2022)

Table 56. Global Transcriptomics Technologies Revenue Forecast by Application (2023-2028)

Table 57. North America Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Transcriptomics Technologies Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Transcriptomics Technologies Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Transcriptomics Technologies Picture

Figure 2. Global Transcriptomics Technologies Revenue Market Share by Type in 2021

Figure 3. Microarrays

Figure 4. Polymerase Chain Reaction (PCR)

Figure 5. Gene Regulation Technologies

Figure 6. Next Generation Sequencing (NGS)

Figure 7. Transcriptomics Technologies Revenue Market Share by Application in 2021

Figure 8. Clinical Diagnostics Picture

Figure 9. Drug Discovery and Research Picture

Figure 10. Bioinformatics Picture

Figure 11. Comparative Transcriptomics Studies Picture

Figure 12. Global Transcriptomics Technologies Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Transcriptomics Technologies Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Transcriptomics Technologies Revenue Market Share by Region (2017-2028)

Figure 15. Global Transcriptomics Technologies Revenue Market Share by Region in 2021

Figure 16. North America Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Transcriptomics Technologies Market Drivers

Figure 22. Transcriptomics Technologies Market Restraints

Figure 23. Transcriptomics Technologies Market Trends

Figure 24. Affymetrix, Inc. Recent Developments and Future Plans

Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 26. Agilent Technologies Recent Developments and Future Plans

Figure 27. F-Hoffmann La Roche Ltd. Recent Developments and Future Plans

Figure 28. Illumina, Inc. Recent Developments and Future Plans

Figure 29. Life Technologies Corporation Recent Developments and Future Plans

Figure 30. Qiangen N.V. Recent Developments and Future Plans

Figure 31. LC Sciences Recent Developments and Future Plans

Figure 32. Sigma-Aldrich Corp Recent Developments and Future Plans

Figure 33. Danaher Corp Recent Developments and Future Plans

Figure 34. Global Transcriptomics Technologies Revenue Share by Players in 2021

Figure 35. Transcriptomics Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Transcriptomics Technologies Revenue Market Share in 2021

Figure 37. Global Top 10 Players Transcriptomics Technologies Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Transcriptomics Technologies Revenue Share by Type in 2021

Figure 40. Global Transcriptomics Technologies Market Share Forecast by Type (2023-2028)

Figure 41. Global Transcriptomics Technologies Revenue Share by Application in 2021

Figure 42. Global Transcriptomics Technologies Market Share Forecast by Application (2023-2028)

Figure 43. North America Transcriptomics Technologies Sales Market Share by Type (2017-2028)

Figure 44. North America Transcriptomics Technologies Sales Market Share by Application (2017-2028)

Figure 45. North America Transcriptomics Technologies Revenue Market Share by Country (2017-2028)

Figure 46. United States Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Transcriptomics Technologies Sales Market Share by Type (2017-2028)

Figure 50. Europe Transcriptomics Technologies Sales Market Share by Application (2017-2028)

Figure 51. Europe Transcriptomics Technologies Revenue Market Share by Country (2017-2028)

Figure 52. Germany Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Transcriptomics Technologies Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Transcriptomics Technologies Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Transcriptomics Technologies Revenue Market Share by Region (2017-2028)

Figure 60. China Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Transcriptomics Technologies Sales Market Share by Type (2017-2028)

Figure 67. South America Transcriptomics Technologies Sales Market Share by Application (2017-2028)

Figure 68. South America Transcriptomics Technologies Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Transcriptomics Technologies Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Transcriptomics Technologies Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Transcriptomics Technologies Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz